01.02.2006 | Progress in Hematology
Rituximab (anti-cd20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment
Erschienen in: International Journal of Hematology | Ausgabe 1/2006
Einloggen, um Zugang zu erhalten